Mandate

Vinge advises Alder II in conjunction with the acquisition of Scanacon

September 26, 2018 M&A

Alder II has entered into an agreement together with the management of the company to acquire the entire issued share capital of Scanacon Intressenter from the seller Verdane Capital.

Scanacon will be the first investment in Alder’s new fund, i.e. Alder II. Alder II is a Swedish based investment fund which invests in Nordic sustainable technology companies. The investments focus on established companies in the Nordic region.

Vinge’s team consisted of, among others, Johan Larsson, Albert Wållgren, Filip Brosset, Manne Bergström, Stina Bengtsson, Ludvig Wettergren and Andreas Lexhag which represented the purchaser Alder II in connection with the acquisition.  

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026